Text Size

HMW-Adiponectin is Raised in Newborns

This study has been completed.
Sponsor:
Information provided by:
University of Oslo
ClinicalTrials.gov Identifier:
NCT00438542
First received: February 21, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted
  Purpose

Cross sectional, hospital-based study dealing with adiponectin levels in newborns to mothers with pre-eclampsia. Venus cord blood samples were collected immediately after birth; 30 cases and 62 controls were enrolled into the study. The study was approved by the local ethics committee and all participants gave written consent.


Condition
Pre-Eclampsia

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective

Further study details as provided by University of Oslo:

Study Start Date: July 2003
Estimated Study Completion Date: July 2006
  Eligibility

Ages Eligible for Study:   up to 30 Minutes
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pre-eclampsia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00438542

Sponsors and Collaborators
University of Oslo
Investigators
Study Director: Lars Morkrid, MD, PhD Institute of Clinical Chemistry, Medical Faculty, University of Oslo, Norway
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00438542     History of Changes
Other Study ID Numbers: HMWadpkcb
Study First Received: February 21, 2007
Last Updated: February 21, 2007
Health Authority: Norway: Directorate of Health

Keywords provided by University of Oslo:
Adiponectin, cord blood, pre-eclampsia

Additional relevant MeSH terms:
Eclampsia
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on May 16, 2013